This augmented reality program helps patients alleviate the symptoms of Parkinson’s
In 2018, Tom Finn took his father, Nigel, to a physiotherapy appointment. Nigel was living with vascular dementia, which can ...
Tag: Parkinson’s
Replacing neurons damaged by Parkinson’s, the objective of a new clinical trial
Parkinson's disease is a disease for which there is currently no cure, although there are drugs that can reduce its ...
A sleep disorder is associated with Parkinson’s and can facilitate its early detection
A REM sleep disorder is a precursor to neurodegenerative diseases such as Parkinson's, as confirmed by a study by the ...
A sleep disorder in the REM phase, a precursor to Parkinson’s
Researchers of the Hospital Clínic de Barcelona-Idibaps have shown that isolated rapid eye movement REM sleep behavior disorder (iRBD) is ...
Dementia, Alzheimer’s, Parkinson’s… mortality from neurological diseases increases in Spain
We live longer and older. Life expectancy continues to increase in Spain, but this is not always accompanied by quality ...
Pioneering advances to cure Parkinson’s and chronic pain: Spanish women who could change the course of medicine
The tireless and creative search for a way out or a solution to a problem implies, by default, the belief ...
Luis Aguilar, at risk of developing Huntington’s disease: “There is more hope than a few years ago”
The Huntington's disease is, after Alzheimer's and the Parkinson'sthe third most common neurodegenerative disease. A disease that, being genetic origincan ...
The Germans Trias hospital in Badalona manages to reduce Parkinson’s tremors by 90%
In February 2022, the Germans Trias Hospital became the first Catalan public center to non-invasively treat diseases such as essential ...
Pollution harms mental health and global warming is associated with more suicides
Climate change is shaking the foundations of global health. “It has the potential to undermine decades of progress in global ...
Diabetes drugs test new side effect: slow down Parkinson’s symptoms
On Friday, April 26, at a special news event in Science magazine, two scientists specializing in GLP1 agonists answered questions ...
